feed,title,long_url,short_url
Benzinga,Small-Cap Gain Therapeutics Stock Falls On Phase 1 Data From Its Lead Asset For Parkinson's Disease,https://benzinga.com/general/biotech/24/08/40629671/small-cap-gain-therapeutics-stock-falls-on-phase-1-data-from-its-lead-asset-for-parkinsons-diseas,https://da.gd/aKJWIC
